Indian exporters face US tariff uncertainty

A Mumbai pharmaceutical company delayed its first shipment of nutraceutical products to the US due to fears of potential tariffs on Indian firms. The threat did not materialise, but the company postponed its US expansion plans.

Indian drugmakers are considering diversifying their export markets due to uncertainty over future US tariffs. They are exploring opportunities in Europe, Africa, Latin America, and other regions to reduce dependence on the US market.